• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Clearday and Viveon Health Merge to Create Longevity Care Company

Share:

April 11, 2023

Clearday, a longevity technology company focused on the senior adult care sector, and Viveon Health Acquisition Corp, a SPAC company, have entered into a merger agreement. Under the deal, Viveon will issue 25 million shares to Clearday security holders, with the combined company’s pro forma equity valuation expected to be approximately $370m. Clearday has transitioned from owning and operating senior-care facilities to an AI-enabled robotics and software business that improves patient outcomes, increases staff efficiency, and unlocks revenue opportunities for operators. The company aims to become the industry’s API for aging in place, serving patients in residential care and nursing facilities and as they age at home.

What You Should Know:

– Clearday, an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp., a special purpose acquisition (SPAC) company have entered into a definitive merger agreement.

– The combined company’s pro forma equity valuation (assuming no share redemptions) is expected to be approximately $370M. VHAQ currently has $20M held in a trust account at Morgan Stanley with Continental Stock Transfer & Trust Company acting as trustee, which was established in connection with VHAQ’s IPO.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Under the terms of the proposed transaction, VHAQ will issue 25 million shares to security holders of Clearday. Clearday security holders may also receive up to an additional five million earn out shares (“Company Earn Out Shares”) if the company achieves profitability for a 12 month period within the first five years after the closing of the transaction.

Clearday Background

Clearday is transitioning from owning and operating senior-care facilities into a high-growth technology business serving the massive, pressing, and expensive longevity care crisis facing our aging population. The Company’s care solution is a combination of AI-enabled robotics and software, delivered in a Platform-as-a-Service that is a drop-in modernization solution for existing resident care facilities which improves patient outcomes, increases staff efficiency, and unlocks premium revenue opportunities for operators.

Clearday has positioned itself to become the industry’s API for aging in place, capable of expanding across the aging continuum to meet patient needs in residential care and skilled nursing facilities, and eventually as they age at home. Only Clearday’s platform integrates the necessary autonomous companionship, care intelligence, and patient data platform to address the challenges in the massive longevity care space.

Source: HitConsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Scripps Bigshot who Cofounded Synthorx Exits amid Mystery
  • Mighty Health Raises $7.6M for Daily Health Program for Medicare-Aged AdultsMighty Health Raises $7.6M for Daily Health Program for Medicare-Aged Adults
  • 3 ways blockchain can change healthcare3 ways blockchain can change healthcare
  • Sidekickhealth to Provide Digital Platform for COVID-19 Patients in IcelandSidekickhealth to Provide Digital Platform for COVID-19 Patients in Iceland
  • Former Twitter CEO Joins eMed HealthcareFormer Twitter CEO Joins eMed Healthcare
  • Bayer completes biggest acquisition in its historyBayer completes biggest acquisition in its history
  • Ligand to Acquire Pfenex Inc.Ligand to Acquire Pfenex Inc.
  • Rheumatoid Arthritis Drugs Market: Use of Rheumatoid Arthritis Drugs in Treating COVID-19 May Serve As a Game-Changer for GrowthRheumatoid Arthritis Drugs Market: Use of Rheumatoid Arthritis Drugs in Treating COVID-19 May Serve As a Game-Changer for Growth

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications